ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $29,000 | -76.6% | 7,796 | -81.9% | 0.01% | -75.0% |
| Q4 2017 | $124,000 | -1.6% | 43,096 | +57.4% | 0.03% | +47.4% |
| Q2 2017 | $126,000 | -61.0% | 27,383 | -64.3% | 0.02% | -48.6% |
| Q1 2017 | $323,000 | +107.1% | 76,783 | +103.1% | 0.04% | +85.0% |
| Q4 2016 | $156,000 | -47.8% | 37,800 | +2.4% | 0.02% | -48.7% |
| Q3 2016 | $299,000 | +1561.1% | 36,900 | +1504.3% | 0.04% | +1850.0% |
| Q2 2016 | $18,000 | -94.9% | 2,300 | -94.2% | 0.00% | -95.7% |
| Q2 2015 | $350,000 | – | 39,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |